Malaria

Meeting documents - MPAC Meeting, 11-13 September 2012


Full meeting report

Session 1 - Report from the WHO Global Malaria Programme Director

Session 2 - Drug Resistance and Containment TEG meeting report and recommendations

Session 3 - Malaria Burden Estimation ERG meeting report and recommendations

Session 4

a) Briefing on RTS,S/AS01 Malaria Vaccine
b) IPTp-SP ERG meeting report and recommendations

Session 5 - Primaquine single dose for P. falciparum ERG meeting report and recommendations

Session 6 - Developing the malaria strategy mix for 2015-2025

Session 7 - Proposed policy setting mechanisms for malaria vector control

Session 8

a) Developing a P. vivax global strategy and investment case
b) Chemotherapy TEG terms of reference

Session 9 - Updating the WHO guidelines for malaria treatment

a) Updating the WHO guidelines for malaria treatment
b) Briefing on AMFm and the independent evaluation

Session 10 - Promoting quality assured diagnostic testing and treatment in the private sector

Conclusions

Survey on stakeholder perceptions

The WHO Global Malaria Programme and the MPAC are seeking input from Member States and the global malaria community on their perceptions of the MPAC. Click here to complete the survey (until 9 May).

Suggestions?

MPAC welcomes agenda suggestions and feedback through mpacgmp@who.int – If appropriate, the relevant TEG or ERG will review the evidence before the subject is discussed in open session; this is the mechanism by which MPAC makes its policy recommendations.